The European Commission (EC) is proposing to adjust intellectual property (IP) rules to help Europe’s pharma companies tap into fast-growing global markets.
Are you prepared for the upcoming changeover to the new EU risk management plan (RMP) template? Seema Jaitly offers some timely guidance on the new EU RMP document.
Amsterdam chosen as the new home of the European Medicines Agency.
Joseph Gulfo the latest name to be put forward for FDA Commissioner